Ardelyx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. 

CEO
Michael G. Raab
CEOMichael G. Raab
Employees
489
Employees489
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2007
Founded2007
Employees
489
Employees489

ARDX Key Statistics

Market cap
980.55M
Market cap980.55M
Price-Earnings ratio
-17.29
Price-Earnings ratio-17.29
Dividend yield
Dividend yield
Average volume
6.76M
Average volume6.76M
High today
$3.98
High today$3.98
Low today
$3.86
Low today$3.86
Open price
$3.93
Open price$3.93
Volume
518.21K
Volume518.21K
52 Week high
$8.40
52 Week high$8.40
52 Week low
$3.86
52 Week low$3.86

Stock Snapshot

As of today, Ardelyx(ARDX) shares are valued at $3.94. The company's market cap stands at 980.55M, with a P/E ratio of -17.29.

On 2026-08-14, Ardelyx(ARDX) stock moved within a range of $3.86 to $3.98. With shares now at $3.94, the stock is trading +1.9% above its intraday low and -1.1% below the session's peak.

Trading volume for Ardelyx(ARDX) stock has reached 518.21K, versus its average volume of 6.76M.

The stock's 52-week range extends from a low of $3.86 to a high of $8.40.

The stock's 52-week range extends from a low of $3.86 to a high of $8.40.

ARDX News

Simply Wall St 18h
Ardelyx Is Down 19.1% After ESOP Shelf Filing And Higher 2026 Product Revenue Guidance

In early August 2026, Ardelyx filed a US$36 million shelf registration for 9,000,000 common shares tied to an ESOP-related offering and reported second-quarter...

Ardelyx Is Down 19.1% After ESOP Shelf Filing And Higher 2026 Product Revenue Guidance
TipRanks 4d
Ardelyx price target lowered to $11 from $14 at Citi

Citi lowered the firm’s price target on Ardelyx (ARDX) to $11 from $14 and keeps a Buy rating on the shares. Unlock powerful investing tools with TipRanks Prem...

Simply Wall St 6d
Ardelyx Stock Slides As Payer Friction Clouds Growth Path

Ardelyx stock just dropped 17.9% to about US$4, extending a three month slide that has taken roughly 41% off the share price. The hit looks harsh when set again...

Ardelyx Stock Slides As Payer Friction Clouds Growth Path

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.